Screener Summaries Updates Institutions Sign In More Updates › Mergers & Acquisitions › APGE Mergers & Acquisitions · Jun 22, 2026
Apogee Therapeutics, Inc. entered into a merger agreement with Andor LLC and AbbVie Inc. to be acquired in a cash… APGE Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. entered into a merger agreement with Andor LLC and AbbVie Inc. to be acquired in a cash transaction for $135.11 per share. The deal is subject to stockholder approval and regulatory clearances. Apogee Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics.
More from Apogee Therapeutics, Inc. On September 3, 2026, Apogee Therapeutics completed its merger with Andor LLC, a subsidiary of AbbVie Inc., becoming… Sep 3, 2026 Apogee Therapeutics stockholders approved the proposed merger with AbbVie subsidiary Andor LLC at a special meeting on… Aug 11, 2026 Apogee Therapeutics reported second quarter 2026 financial results and announced that AbbVie will acquire the company… Aug 10, 2026 On June 17, 2026, Apogee Therapeutics entered into an antibody discovery agreement and a contemporaneous license… Jun 22, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
